Idelalisib as a Bridge to Allogeneic Transplantation in Relapsed/Refractory Lymphoma With Renal Cancer: A Case Report

Follicular lymphoma (FL) is the most common indolent mature B-cell lymphoma in the Western world.1 Clinical presentation is often characterized by a slow-onset asymptomatic lymphadenopathy with a relapsing and remitting disease course. Grading of FL (from 1 to 3) is mandatory. Moreover, grade 3 FL has been divided into grades 3a and 3b.1 The higher the grade, the more aggressive the clinical course.2 The trigger point for starting treatment remains a difficult question. Watchful waiting is an acceptable approach, whereas immunochemotherapy is currently the standard of care for patients with advanced-stage FL who are in need of treatment.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Tags: Case Report Source Type: research